Announced Thu, 16 Jul · 14:53 IST
Alkem infuses Rs 1,100 crore into subsidiary for Occlutech acquisition
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.9%1-day move
₹5654.00
prior close
₹5722.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-0.1-0.2-0.3-1.9-0.0+0.5-1.2-0.8-0.7————
Up moveDown movePending
AI summary
Alkem Laboratories has invested Rs 1,100 crore in its wholly owned subsidiary Alkem Medtech by subscribing to rights shares at Rs 13.86 each. The subsidiary will use this funding to acquire 51 to 55 percent stake in Occlutech Holding AG, a foreign medical device company in cardiovascular and orthopedic segments. Alkem Medtech was incorporated in March 2024 and reported a turnover of Rs 15.13 crores in FY26. The transaction was completed on 15th July 2026.
Likely market impact
Rs 1,100 crore capital infusion into subsidiary for overseas acquisition in medical devices. Expands Alkem's presence in cardiovascular and orthopedic segments.